COMPANY PROFILE

Click Therapeutics

Explore full profile

Develops and commercializes software as prescription medical treatments for people with unmet medical needs

New York City, United StatesFounded 2012Biotech & Life Sciences

Valuation $250–500M Last recorded · 2026

Revenue $1–10M Latest reported FY

Headcount 100–500 Current team size

Total funding $100–500M Disclosed equity funding

Unlock exact values

About Click Therapeutics

Click Therapeutics is a biotechnology startup that operates in the digital health sector, specifically in the emerging field of digital therapeutics. The company develops, validates, and commercializes software as prescription medical treatments for patients with unmet medical needs. This means they create software applications that are used like medicine, either on their own or alongside traditional treatments, to help patients manage their health conditions.

The company's business model is based on the development of these software applications, which are designed to alter the cognitive and neurobehavioral mechanisms that underlie various diseases. These applications are rigorously tested through randomized, controlled trials to ensure their safety and effectiveness. Once validated, the company seeks clearance from the FDA to market these apps as class II medical devices.

Click Therapeutics' revenue comes from physicians who prescribe their apps and from payers who reimburse for them. The company also uses real-world evidence to continuously improve and personalize their applications.

One of their notable collaborations is with Boehringer Ingelheim, a leading pharmaceutical company, to develop and commercialize a novel prescription digital therapeutic to aid in the treatment of schizophrenia. This partnership is worth $500 million, indicating the significant potential of digital therapeutics in the healthcare market.

The company's leadership team includes CEO David B. Klein, CFO, CTO, Chief Strategy Officer Austin C. Speier, and Chief Medical Officer Shaheen Lakhan, MD, PhD, FAAN, among others.

MoreLess Source: Dealroom company data

At a glance

Status: Operational
Founded: 2012
Headquarters: New York City, United States
Employees: 117
Open positions: 2
Dealroom signal: 62.5/100
Industry: Health
Sub-industry: Pharmaceutical, Medical Devices
Sector: Biotech & Life Sciences, Biotechnology, Mental Health, Sustainable Development Goals, Digital Therapeutics, Tech for Biotech and Pharma, Tech for Patients, Biotech and Pharma, Hard Tech, DT and LS, science-based
Business model: SaaS
Links: Website LinkedIn X

Knowledge graph

News, research, reports and resources connected to this company by Dealroom

Funding history

10 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
SERIES DOther financing	Apr 2026	$50M	$200M	Boehringer Ingelheim	↗
LATE VCOther financing	Mar 2025	$0	—	Dassault Systemes	↗

Showing the latest 2 of 10 recorded eventsBook a demo for the full funding history →

Financials

Revenue over time

Revenue, earnings and other financial measures where available. Years marked “E” are estimates.

Year	Revenue	Growth
2026
2025
2024		—

Company filings, research estimates and Dealroom dataBook a demo for the full financial model →

Growth signals

Click Therapeutics website traffic

Latest recorded traffic for Click Therapeutics is 10K monthly website visits, up 26.6% over the last three months. Click Therapeutics's team declined 23% over the past year.

Latest monthly visits10K 3-month web change+26.6% 1-year team growth-23%

Monthly website visitsOct 2017–Jul 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Open positions

Openings linked to this company in Dealroom

Corporate CounselNew York, New York, United States, Northern America, Americas · Legal · Aug 24, 2026 Director, Marketing (Rx and OTC)Boston, New York, United States, Northern America, Americas · Marketing & Communication · Jul 31, 2026 Senior Software EngineerNew York, New York, United States, Northern America, Americas · Backend Development · Jul 28, 2026 Director / Senior Director, ScienceNew York, New York, United States, Northern America, Americas · Data Science & Engineering · Jul 24, 2026

4 distinct openings shownExplore hiring signals →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
LILimbixPrescription digital therapeutics for adolescent mental health	Palo Alto, United States	Acquired	5	$31M	$60M
OHOmada HealthOnline programs combine world-class science, technology, and design to inspire and enable people everywhere to live free of chronic disease	San Francisco, United States	Operational
IHIeso Digital HealthInternet enabled evidence-based psychological therapies	Cambridge, United Kingdom	Acquired
SHSyrona HealthDigital therapeutics for Endometriosis and Gynaecological Health	London, United Kingdom	Operational
FNFlow NeuroscienceDevelops a new kind of depression treatment which combines an easy-to-use brain stimulation headset with a personalized mobile app	Malmö kommun, Sweden	Operational
KHKaia HealthCreates evidence-based treatments for a range of disorders including musculoskeletal conditions and COPD	Berlin, Germany	Acquired
BIBiofourmisBiotechnology company that augments personalized care and therapies using digital therapeutics	Boston, United States	Operational
ASATAI Life SciencesA biotechnology company pioneering mental health innovation	Berlin, Germany	Acquired